NanoViricides Stock Price, News & Analysis (NYSEAMERICAN:NNVC)

$1.02 0.08 (8.51 %)
(As of 01/21/2018 09:58 AM ET)
Previous Close$1.02
Today's Range$0.92 - $1.03
52-Week Range$0.83 - $1.64
Volume254,895 shs
Average Volume165,095 shs
Market Capitalization$64.60 million
P/E Ratio-6.80
Dividend YieldN/A
Beta0.21

About NanoViricides (NYSEAMERICAN:NNVC)

NanoViricides, Inc. is a nano-biopharmaceutical company. The Company is a development-stage company with several drugs in various stages of development. The Company focuses on its research and clinical programs on specific anti-viral therapeutics. The Company is engaged in the application of nanomedicine technologies to the issues of viral diseases. The Company's nanoviricide technology enables direct attacks at multiple points on a virus particle. In addition, the nanoviricide technology also simultaneously enables attacking the intracellular reproduction of the virus by incorporating one or more active pharmaceutical ingredients (APIs) within the core of the nanoviricide. The nanoviricide technology is engaged in both attacking extracellular virus thereby breaking the reinfection cycle, and simultaneously disrupting intracellular production of the virus, thereby enabling complete control of a virus infection.

Receive NNVC News and Ratings via Email

Sign-up to receive the latest news and ratings for NNVC and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Bio Therapeutic Drugs
Sub-IndustryN/A
SectorHealthcare
SymbolNYSEAMERICAN:NNVC
CUSIPN/A
Phone+1-203-9376137

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E Ratio-6.8
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

Trailing EPS($0.15)
Net IncomeN/A
Net MarginsN/A
Return on Equity-41.43%
Return on Assets-30.78%

Miscellaneous

EmployeesN/A
Outstanding Shares68,830,000

NanoViricides (NYSEAMERICAN:NNVC) Frequently Asked Questions

What is NanoViricides' stock symbol?

NanoViricides trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "NNVC."

How were NanoViricides' earnings last quarter?

NanoViricides Inc (NYSEAMERICAN:NNVC) announced its quarterly earnings data on Tuesday, November, 14th. The company reported ($0.03) earnings per share for the quarter. View NanoViricides' Earnings History.

When will NanoViricides make its next earnings announcement?

NanoViricides is scheduled to release their next quarterly earnings announcement on Monday, February, 12th 2018. View Earnings Estimates for NanoViricides.

Are investors shorting NanoViricides?

NanoViricides saw a decrease in short interest in the month of December. As of December 29th, there was short interest totalling 459,345 shares, a decrease of 44.7% from the December 15th total of 830,252 shares. Based on an average daily volume of 186,490 shares, the short-interest ratio is currently 2.5 days. Approximately 0.9% of the company's stock are short sold.

Who are some of NanoViricides' key competitors?

Who are NanoViricides' key executives?

NanoViricides' management team includes the folowing people:

  • Anil Diwan Ph.D., Chairman of the Board, President (Age 57)
  • Eugene Seymour M.D., Chief Executive Officer, Director (Age 75)
  • Meeta Vyas, Chief Financial Officer (Age 57)
  • Milton Boniuk, Independent Director (Age 83)
  • Stanley Glick CPA, Independent Director (Age 79)
  • Mukund S. Kulkarni Ph.D., Independent Director (Age 68)

How do I buy NanoViricides stock?

Shares of NanoViricides can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is NanoViricides' stock price today?

One share of NanoViricides stock can currently be purchased for approximately $1.02.

How big of a company is NanoViricides?

NanoViricides has a market capitalization of $64.60 million.

How can I contact NanoViricides?

NanoViricides' mailing address is 1 Controls Dr, SHELTON, CT 06484-6153, United States. The company can be reached via phone at +1-203-9376137.


MarketBeat Community Rating for NanoViricides (NNVC)

Community Ranking:  2.9 out of 5 (star star)
Outperform Votes:  34 (Vote Outperform)
Underperform Votes:  24 (Vote Underperform)
Total Votes:  58
MarketBeat's community ratings are surveys of what our community members think about NanoViricides and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

NanoViricides (NYSEAMERICAN:NNVC) Analyst Ratings History


No equities research coverage for this company has been tracked by MarketBeat

Earnings

NanoViricides (NYSEAMERICAN:NNVC) Earnings History and Estimates Chart

Earnings by Quarter for NanoViricides (NYSEAMERICAN:NNVC)

NanoViricides (NYSEAMERICAN NNVC) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/12/2018N/AView Earnings Details
11/14/2017Q1 2018($0.03)ViewN/AView Earnings Details
5/15/2017Q3 2017($0.05)ViewN/AView Earnings Details
2/14/2017Q2 2017($0.04)ViewN/AView Earnings Details
11/15/2016Q1 2017($0.05)ViewN/AView Earnings Details
9/16/2016Q4 2016($0.03)ViewN/AView Earnings Details
5/11/2016Q3 2016($0.09)ViewN/AView Earnings Details
2/9/2016Q2 2016($0.05)ViewN/AView Earnings Details
11/9/2015Q1 2016($0.02)ViewN/AView Earnings Details
9/14/2015Q4 2015($0.05)ViewN/AView Earnings Details
5/18/2015Q3 2015($0.02)ViewN/AView Earnings Details
2/25/2015Q215($0.05)($0.03)$1.75 million$1.82 millionViewN/AView Earnings Details
10/2/2014($0.04)($0.07)ViewN/AView Earnings Details
5/20/2014($0.04)($0.01)ViewN/AView Earnings Details
2/14/2014Q2 2014($0.04)($0.03)ViewN/AView Earnings Details
11/18/2013Q1 2014($0.13)ViewN/AView Earnings Details
10/1/2013Q4 2013($0.05)ViewN/AView Earnings Details
5/15/2013Q3 2013($0.07)ViewN/AView Earnings Details
2/19/2013Q2 2013($0.04)ViewN/AView Earnings Details
11/19/2012Q1 2013($0.04)ViewN/AView Earnings Details
10/15/2012Q4 2012($0.04)ViewN/AView Earnings Details
5/17/2012Q3 2012($0.04)ViewN/AView Earnings Details
2/15/2012Q2 2012($0.03)ViewN/AView Earnings Details
11/15/2011Q1 2012($0.04)($0.03)ViewN/AView Earnings Details
10/13/2011Q4 2011($0.03)ViewN/AView Earnings Details
5/23/2011Q3 2011($0.04)($0.01)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

NanoViricides (NYSEAMERICAN:NNVC) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for NanoViricides (NYSEAMERICAN:NNVC)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

NanoViricides (NYSEAMERICAN NNVC) Insider Trading and Institutional Ownership History

Insider Trades by Quarter for NanoViricides (NYSEAMERICAN:NNVC)

NanoViricides (NYSEAMERICAN NNVC) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
10/22/2015Milton BoniukDirectorBuy25,000$1.30$32,500.00View SEC Filing  
9/11/2015Milton BoniukDirectorBuy50,000$1.02$51,000.00View SEC Filing  
8/26/2015Milton BoniukDirectorBuy50,000$1.05$52,500.001,705,391View SEC Filing  
7/8/2015Milton BoniukDirectorBuy50,000$1.58$79,000.00View SEC Filing  
5/20/2015Milton BoniukDirectorBuy50,000$1.60$80,000.00View SEC Filing  
5/8/2015Milton BoniukDirectorBuy405,954$2.58$1,047,361.32View SEC Filing  
1/12/2015Anil DiwanMajor ShareholderBuy14,000$2.56$35,840.00View SEC Filing  
1/6/2015Milton BoniukDirectorBuy25,000$2.60$65,000.00View SEC Filing  
12/9/2014Milton BoniukDirectorBuy50,000$3.05$152,500.00View SEC Filing  
7/17/2014Milton BoniukDirectorBuy57,144$3.50$200,004.00View SEC Filing  
2/20/2014Anil DiwanMajor ShareholderBuy50,000$3.61$180,500.00View SEC Filing  
10/21/2013Anil DiwanMajor ShareholderSell142,000$5.29$751,180.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

NanoViricides (NYSEAMERICAN NNVC) News Headlines

Source:
DateHeadline
NanoViricides Inc (NNVC) Short Interest Down 44.7% in DecemberNanoViricides Inc (NNVC) Short Interest Down 44.7% in December
www.americanbankingnews.com - January 11 at 1:24 AM
Short Interest in NanoViricides Inc (NNVC) Drops By 19.1%Short Interest in NanoViricides Inc (NNVC) Drops By 19.1%
www.americanbankingnews.com - December 28 at 2:09 AM
NanoViricides, Inc. (NNVC) Sees Significant Decline in Short InterestNanoViricides, Inc. (NNVC) Sees Significant Decline in Short Interest
www.americanbankingnews.com - December 12 at 2:26 AM
NanoViricides, Inc. (NNVC) Short Interest UpdateNanoViricides, Inc. (NNVC) Short Interest Update
www.americanbankingnews.com - November 27 at 9:30 PM
NanoViricides Files Quarterly Report for Period Ending September 30, 2017NanoViricides Files Quarterly Report for Period Ending September 30, 2017
finance.yahoo.com - November 21 at 8:40 AM
Is NanoViricides Inc (NNVC) A Financially Sound Company?Is NanoViricides Inc (NNVC) A Financially Sound Company?
finance.yahoo.com - November 21 at 8:40 AM

SEC Filings

NanoViricides (NYSEAMERICAN:NNVC) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

NanoViricides (NYSEAMERICAN:NNVC) Income Statement, Balance Sheet and Cash Flow Statement

Chart

NanoViricides (NYSEAMERICAN NNVC) Stock Chart for Sunday, January, 21, 2018

Loading chart…

This page was last updated on 1/21/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.